FDA
approval
· 2022-08-31
FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
Summary
FDA approved a supplemental application for tenofovir disoproxil fumarate filed by Macleods Pharmaceuticals Limited under the ANDA process.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE)